On Nov. 19, 2021, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) expanded recommendations for booster doses to include all adults ages 18 years and older who received a Pfizer-BioNTech or Moderna COVID-19 vaccine primary series. The booster dose may be administered at least six (6) months after the completion of a two-dose primary series of either mRNA COVID-19 vaccine product. Healthy people who were not previously recommended for a booster dose may now receive one if they completed a primary mRNA COVID-19 vaccine series six (6) or more months ago.
In addition, the ACIP updated recommendations for the groups that should receive a booster dose at least six (6) months after completing a primary mRNA COVID-19 vaccine series to include all individuals ages 50 years and older and all residents of long-term care settings who are 18 years and older. Although these recommendations are specific to mRNA COVID-19 vaccine recipients, individuals eligible for a booster dose are able to choose to receive any of the COVID-19 vaccines currently authorized in the United States for their booster dose.
There were no changes to CDC’s existing booster dose recommendations for recipients of Johnson & Johnson’s (J&J) Janssen COVID-19 vaccine. All individuals who received an initial dose of the J&J COVID-19 vaccine should receive a booster dose at least two (2) months after receiving the initial vaccination.
For more information, guidance and resources about the COVID-19 response in Nevada, visit https://nvhealthresponse.nv.gov/.